first_imgNew Delhi: Drug major Sun Pharmaceutical Industries Tuesday reported a consolidated net profit of Rs 635.88 crore for the fourth quarter ended on March 31, 2019. The company had posted a net profit of Rs 1,342.50 crore for the corresponding period of the previous fiscal, Sun Pharmaceutical Industries said. The profit was mainly impacted by distribution change for its India business. The company said the net profit for the fourth quarter of FY2018-19 is not comparable with the year-ago period due to the one-time impact of distribution change for India business in the fourth quarter of 2018-19 as well as the one-time tax benefit of Rs 259 crore for the same quarter during the last year.last_img

Leave a Reply

Your email address will not be published. Required fields are marked *